Hypertension, Vol 17, 469-477, Copyright © 1991 by American Heart Association
WA Hsueh and JD Baxter
Human prorenin is the enzymatically inactive biosynthetic precursor of
renin. Recent interest has focused on the posttranslational sorting and
processing of prorenin to renin since markedly increased levels of
circulating prorenin have been associated with both physiological and
pathological changes. These observations raise the question of whether
prorenin processing may be a regulatory event in renin production in the
kidney. In the juxtaglomerular cells of the kidney, prorenin can be sorted
to either of two pathways: 1) the regulated pathway, which is mediated by
secretory granules, where a thiol protease resembling cathepsin B processes
prorenin to renin by cleavage of the amino terminal 43-amino acid
prosegment, which allows exposure of the active site of renin, or 2) the
constitutive pathway, which is not regulated and does not involve
conversion of prorenin to renin. Studies in which segments of prorenin are
modified by site-directed mutagenesis suggest that the prosegment and
glycosylation are not required for sorting, although they may influence or
participate in sorting, or both. Certain areas in the prosegment are
important determinants of enzyme activity and ability to cleave the
prosegment. Further structural analysis of prorenin will be useful to
assess details of its sorting and processing. In addition, a number of
extrarenal tissues such as uterine lining, ovarian theca, corpus luteum,
pituitary, and adrenal, express the renin gene. These tissues have
different capabilities to sort and process prorenin compared with kidney,
and some tissues secrete only prorenin. Whether prorenin-to-renin
conversion is necessary to activate these local renin-angiotensin systems
is a key issue.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Human prorenin
Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.
This article has been cited by other articles:
![]() |
J. L. Wilkinson-Berka and D. J. Campbell (Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy? Diabetes, July 1, 2009; 58(7): 1485 - 1487. [Full Text] [PDF] |
||||
![]() |
C. Mercure, G. Prescott, M.-J. Lacombe, D. W. Silversides, and T. L. Reudelhuber Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies Hypertension, June 1, 2009; 53(6): 1062 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, N. A. Noble, W. A. Border, R. T. Owens, and Y. Huang Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E810 - E819. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Campbell Critical Review of Prorenin and (Pro)renin Receptor Research Hypertension, May 1, 2008; 51(5): 1259 - 1264. [Full Text] [PDF] |
||||
![]() |
V. Laurent-Matha, D. Derocq, C. Prebois, N. Katunuma, and E. Liaudet-Coopman Processing of human cathepsin d is independent of its catalytic function and auto-activation: involvement of cathepsins L and B. J. Biochem., March 1, 2006; 139(3): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Suzuki, M. Hayakawa, T. Nakagawa, U. M. Nasir, A. Ebihara, A. Iwasawa, Y. Ishida, Y. Nakamura, and K. Murakami Human Prorenin Has "Gate and Handle" Regions for Its Non-proteolytic Activation J. Biol. Chem., June 13, 2003; 278(25): 22217 - 22222. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey and H. M. Siragy Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation Endocr. Rev., June 1, 2003; 24(3): 261 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peters, R. Farrenkopf, S. Clausmeyer, J. Zimmer, S. Kantachuvesiri, M. G.F. Sharp, and J. J. Mullins Functional Significance of Prorenin Internalization in the Rat Heart Circ. Res., May 31, 2002; 90(10): 1135 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Almeida, V. Oliveira, J. R. Chagas, M. Meldal, M. A. Juliano, and L. Juliano Hydrolysis by Cathepsin B of Fluorescent Peptides Derived From Human Prorenin Hypertension, June 1, 2000; 35(6): 1278 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ichihara, H. Suzuki, Y. Miyashita, M. Naitoh, M. Hayashi, and T. Saruta Transmural pressure inhibits prorenin processing in juxtaglomerular cell Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R220 - R228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deinum, F. H.M. Derkx, and M. A.D.H. Schalekamp Improved Immunoradiometric Assay for Plasma Renin Clin. Chem., June 1, 1999; 45(6): 847 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Methot, D. W. Silversides, and T. L. Reudelhuber In Vivo Enzymatic Assay Reveals Catalytic Activity of the Human Renin Precursor in Tissues Circ. Res., May 14, 1999; 84(9): 1067 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Muller, K. F. Hilgers, S. Mathews, V. Breu, W. Fischli, R. Uhlmann, and F. C. Luft Effects of Human Prorenin in Rats Transgenic for Human Angiotensinogen Hypertension, January 1, 1999; 33(1): 312 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Karginova, E. S. Pentz, I. G. Kazakova, V. F. Norwood, R. M. Carey, and R. A. Gomez Zis: a developmentally regulated gene expressed in juxtaglomerular cells Am J Physiol Renal Physiol, November 1, 1997; 273(5): F731 - F738. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Methot, M. C. LaPointe, R. M. Touyz, X.-P. Yang, O. A. Carretero, C. F. Deschepper, E. L. Schiffrin, G. Thibault, and T. L. Reudelhuber Tissue Targeting of Angiotensin Peptides J. Biol. Chem., May 16, 1997; 272(20): 12994 - 12999. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Milsted, M. Nishimura, K. B. Brosnihan, and C. M. Ferrario Differential Regulation of Angiotensinogen Transcripts After Renin Infusion Hypertension, October 1, 1996; 28(4): 678 - 681. [Abstract] [Full Text] |
||||
![]() |
C. Mercure, G. Thibault, S. Lussier-Cacan, J. Davignon, E. L. Schiffrin, and T. L. Reudelhuber Molecular Analysis of Human Prorenin Prosegment Variants in Vitro and in Vivo J. Biol. Chem., July 7, 1995; 270(27): 16355 - 16359. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Fortenberry and J. M. Chirgwin The Propeptide Is Nonessential for the Expression of Human Cathepsin D J. Biol. Chem., April 28, 1995; 270(17): 9778 - 9782. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |